, Volume 468, Issue 9, pp 2363-2371,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 29 Apr 2010

Factors That Predict Short-term Complication Rates After Total Hip Arthroplasty

Abstract

Background

There remains uncertainty regarding the relative importance of patient factors such as comorbidity and provider factors such as hospital volume in predicting complication rates after total hip arthroplasty (THA).

Purpose

We therefore identified patient and provider factors predicting complications after THA.

Methods

We reviewed discharge data from 138,399 patients undergoing primary THA in California from 1995 to 2005. The rate of complications during the first 90 days postoperatively (mortality, infection, dislocation, revision, perioperative fracture, neurologic injury, and thromboembolic disease) was regressed against a variety of independent variables, including patient factors (age, gender, race/ethnicity, income, Charlson comorbidity score) and provider variables (hospital volume, teaching status, rural location).

Results

Compared with patients treated at high-volume hospitals (above the 20th percentile), patients treated at low-volume hospitals (below the 60th percentile) had a higher aggregate risk of having short-term complications (odds ratio, 2.00). A variety of patient factors also had associations with an increased risk of complications: increased Charlson comorbidity score, diabetes, rheumatoid arthritis, advanced age, male gender, and black race. Hispanic and Asian patients had lower risks of complications.

Conclusions

Patient and provider characteristics affected the risk of a short-term complication after THA. These results may be useful for educating patients and anticipating perioperative risks of THA in different patient populations.

Level of Evidence

Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

One or more of the authors (NFS) received funding from the Orthopaedic Research and Education Foundation.
Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
This work was performed at the UCLA School of Medicine.